Learn about the Russian Corona vaccine Sputnik V, which is recognized in India

Moscow, April 14, 2021, Monday

Russian scientists claim to have discovered the world's first Sputnik-V vaccine for the corona virus. However, the Sputnik-V vaccine took a long time to be approved due to lack of adequate trials and data at the time. Now the trial of Phase-3 of this vaccine is in its final stage. According to the information received, the vaccine, which received the first regulatory approval in the world, has been approved in India. Covishield and Covacion were approved in India last January, including Sputnik Knock. However Sputnik V is only allowed in case of emergency.

It is therefore important to know how different Russia's Sputnik-V differs from the two previously approved vaccines. The final results of Phase 2 show that the efficiency of Sputnik V is 91.5%. A total of 1,200 people were tried. Apart from India, Phase-II trials of the Sputnik vaccine are also underway in the UAE, Venezuela and Belarus. Sputnik has so far been approved by six countries. The resistance of these corona vaccines is based on adenovirus-2, (AD-2) and adenovirus-2 (AD-2), which cause respiratory problems. The interval between two doses of this vaccine is 21 days. Usually both doses of the vaccine have the same type of drug but the doses of Sputnik have different drugs.

A special committee of the Central Pharmaceutical Authority of India has approved Sputnik with certain conditions. Following this approval, the General Controller of Medicines (DCGI) will take the final decision. Russia's vaccine has made its way into India as corona infections in India are increasing by leaps and bounds. Last Sunday, the country received 1.5 lakh cases of corona in two hours, which is the highest in the world. It is hoped that this third vaccine will serve as a stronger weapon in the event that corona infections increase in the future and the situation becomes uncontrollable.

Abroad, a dose of Sputnik vaccine costs ૧૦ 10

The effectiveness of Bharat Biotech's Covacation's Phase-3 clinical trial was found to be 91%. Efficacy of Covishield of Serum Institute of India was recorded at 9%, however, after giving one and a half doses, the efficiency reached 80%. The Sputnik vaccine is given in two doses just like any other vaccine. Can be stored between 3 to 4 degrees Celsius. Both Covishield and Covexion are provided free of cost in government hospitals while Rs 50 is charged at private places. It is not yet clear how much Sputnik V will cost in India. Abroad, a dose of Sputnik vaccine costs ૧૦ 10. Initially Sputnik V will be imported from Russia so its price is likely to increase. Once the production of this vaccine starts in India, it will be much cheaper. A deal has been struck with a reputed medical institute in India to prepare 100 million doses.

The vaccine is named after the first artificial satellite, Sputnik

Russia has named the vaccine Sputnik after the first satellite launched into space on the 19th. Once upon a time, there was a bitter rivalry between the Soviet Union (Russia) and the United States in space science. Russia made history by launching America's first artificial satellite, Sputnik. Russia also competed with the United States in finding the corona vaccine. Russia overtook the United States last August when it claimed to have found a vaccine when vaccine research in the world was stuck in the first and second trials.

Russia has been accused of stealing data from Vaccine Research

However there was a vaccine controversy over the issue of making vaccine research and trial data public. The United States and European countries have accused Russia of stealing research data and developing vaccines. Cyber ​​security agencies in the United States, Britain and Canada have blamed APT-2 (Cozy Bear), a hacking group linked to Russia's security agencies, and said it was part of a Russian spy agency operating at the behest of the Kremlin. . The Sputnik vaccine has been developed by Russia's Gamalya Research Center. The full name of the institute is Gamalaya National Research Center for Epidemiology and Microbiology. The research center also developed the first Ebola vaccine.

Click here for more information